Buy BPC-157 & TB-500 Blend — Synedica 40mg Injection Pen Kit
If you want to buy BPC-157 & TB-500 blend in the most advanced delivery format available, the Synedica 40mg Injection Pen Kit is the only pre-loaded, ready-to-use dual-peptide pen on the market. No reconstitution. No measuring. No separate supplies. Just a precision 70% TB-500 / 30% BPC-157 blend in a single cartridge — ready the moment it arrives.
This is the BPC-157 & TB-500 blend for sale that biohackers and recovery researchers have been looking for: a disclosed ratio, a convenient pen format, and a 40mg cartridge that supports multi-week structured protocols from a single kit.
What Makes This the Best BPC-157 & TB-500 Blend for Sale?
Most BPC-157 TB-500 blends on the market are sold as lyophilized powder vials. That means you need bacteriostatic water, separate syringes, precise measuring equipment, and reconstitution skills before you can even begin a research protocol. The Synedica pen eliminates every one of those steps.
- Pre-loaded 40mg pen — ready to use straight out of the kit, zero preparation required
- Disclosed 70/30 blend ratio — 70% TB-500 / 30% BPC-157, stated at every dose level
- Precise dose increments — 2.5mg, 5mg, 7.5mg, or 10mg per administration
- Everything included — 1 pen, 12 disposable 32g 4mm needles, full dosing guide booklet
- No reconstitution — no bacteriostatic water, no syringes, no measuring equipment needed
- Fast USA shipping — in stock and dispatched within 1 business day
Exact Blend Ratio at Every Dose
When you buy BPC-157 & TB-500 blend, knowing the exact compound split matters. The Synedica pen discloses the full ratio at every increment — unlike many blends that list a combined total without specifying the individual breakdown.
| Dose | TB-500 (70%) | BPC-157 (30%) | Doses per pen |
|---|---|---|---|
| 2.5mg | 1.75mg | 0.75mg | 16 doses |
| 5mg | 3.5mg | 1.5mg | 8 doses |
| 7.5mg | 5.25mg | 2.25mg | 5 doses |
| 10mg | 7mg | 3mg | 4 doses |
What Is BPC-157?
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid pentadecapeptide derived from a protein found in gastric juice. It has been investigated in over 180 peer-reviewed preclinical studies for its role in VEGFR2 receptor activation, nitric oxide signaling, fibroblast migration, and angiogenesis — the formation of new blood vessels in tissue models. It is produced and sold strictly for controlled R&D applications.
What Is TB-500?
TB-500 is a synthetic analog of Thymosin Beta-4 (Tβ4), a highly conserved actin-binding protein documented in over 900 scientific publications. In laboratory research it is studied for cytoskeletal reorganisation, systemic cell migration, anti-inflammatory cytokine modulation, and structural remodeling in preclinical models. TB-500 is not limited to specific receptor targets, making it one of the most versatile peptides studied in recovery-focused research.
Why BPC-157 & TB-500 Are Studied Together
The reason researchers specifically look to buy BPC-157 & TB-500 blend rather than either compound alone is the complementary mechanism hypothesis. In preclinical research:
- BPC-157 is associated with localised vascular stabilisation — activating VEGFR2, restoring blood flow, and initiating the cellular repair cascade at the endothelial level
- TB-500 is studied for what follows — amplifying cellular motility, reorganising the cytoskeleton via actin-binding, and driving structural remodeling to complete the repair process
Together they target different rate-limiting steps in the same biological process — making the BPC-157 TB-500 blend for sale in combined form the preferred research design over sequential single-peptide protocols.
What Is Included in the Kit?
- 1 × Pre-loaded 40mg BPC-157 & TB-500 injection pen — 70% TB-500 / 30% BPC-157
- 12 × Disposable 32 gauge 4mm needles
- 1 × Full instruction and dosing guide booklet
R&D Applications
This BPC-157 & TB-500 blend pen kit is produced exclusively for the following controlled research and development applications:
- Angiogenesis and VEGFR2 signaling pathway research — BPC-157 component
- Actin-binding, cytoskeletal organisation and cell migration studies — TB-500 component
- Dual-peptide fibroblast activity and wound repair biology models
- Anti-inflammatory cytokine signaling pathway investigation
- Tissue-level structural remodeling studies
- Peptide stability, shelf-life, and formulation robustness evaluation
Frequently Asked Questions
Where can I buy BPC-157 & TB-500 blend in pen kit format?
The Synedica BPC-157 & TB-500 40mg Injection Pen Kit is available directly at synedica.us. It is one of the few BPC-157 & TB-500 blends for sale in a pre-loaded pen format — no reconstitution required. In stock with fast USA shipping.
What is the blend ratio in the Synedica BPC-157 & TB-500 pen?
The Synedica pen uses a 70% TB-500 / 30% BPC-157 precision blend across the full 40mg cartridge. At 10mg per dose: 7mg TB-500 + 3mg BPC-157. At 5mg: 3.5mg TB-500 + 1.5mg BPC-157. The ratio is fully consistent at every dose increment.
How is the Synedica pen kit different from other BPC-157 TB-500 blends for sale?
Most BPC-157 TB-500 blends for sale are lyophilized powder vials requiring reconstitution with bacteriostatic water, separate syringes, and precise measuring. The Synedica pen is pre-loaded, discloses the exact 70/30 ratio, includes all needles, and is ready to use immediately — making it the most convenient format for structured multi-week research protocols.
How many doses does the 40mg pen contain?
At the standard 5mg research setting: 8 doses per pen. At 2.5mg: 16 doses. At 7.5mg: 5 doses. At 10mg: 4 full doses. The dose increment is fully configurable between 2.5mg and 10mg per administration.
Does the BPC-157 & TB-500 blend pen require reconstitution?
No. Unlike lyophilized BPC-157 TB-500 powder vials, the Synedica pen is pre-loaded and ready to use. No bacteriostatic water, measuring equipment, or reconstitution skills are required.
What is BPC-157 used for in laboratory research?
BPC-157 (Body Protection Compound-157) is a 15-amino-acid synthetic peptide studied in preclinical models for VEGFR2 activation, nitric oxide signaling, fibroblast migration, and angiogenesis. It is produced and sold for controlled R&D applications only — not for human or animal use.
What is TB-500 and how does it work alongside BPC-157?
TB-500 is a synthetic analog of Thymosin Beta-4 (Tβ4), studied for actin-binding, cytoskeletal reorganisation, and systemic cell migration. In combined BPC-157 TB-500 blend research, BPC-157 targets localised vascular signaling while TB-500 drives the broader cellular motility and remodeling response — addressing complementary mechanisms in the same research model.
⚠️ All Synedica products are produced exclusively for controlled laboratory research and development applications. Not for human or animal consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.
Related Products
- Buy Biotin Injection Pen for wellness support
- Buy Melanotan 2 Nasal Spray online
- Tirzepatide peptide for weight management
- TRT HCG kit for hormone optimization
